先声药业(02096)于2026年10月27日发布公告，披露当日于香港联交所回购公司股份。此次回购股份数量为104.20万股，约占公司已发行股本的0.04%，每股回购价介乎港币10.15元至10.41元，合计耗资约1,075.10万港元。
公告显示，本次回购完成后，公司已发行股本总数仍为2,568,198,618股，库藏股数为0。根据2026年6月12日通过的回购授权，先声药业可回购的股份总数为256,819,861股，迄今已累计回购11,829,000股，占授权总额的4.61%。
公司同时确认，本次股份回购已取得董事会正式授权，并遵守了香港联交所证券上市规则及相关法律法规。公告由联席公司秘书朱达签署。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.